NCT00690261

Brief Summary

The purpose of this study is to evaluate the correlation between M1/M2 phenotype of tumor associated macrophage (TAM) in lung cancer patients and clinical outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2008

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
Last Updated

June 4, 2008

Status Verified

May 1, 2008

First QC Date

June 1, 2008

Last Update Submit

June 3, 2008

Conditions

TumorLung Cancer

Keywords

tumor associated macrophagelung canceroutcome

Outcome Measures

Primary Outcomes (1)

  • outcome (treatment response and mortality)

    3 years

Secondary Outcomes (1)

  • clinical presentation

    at enrollement

Study Arms (1)

lung cancer

patients diagnosed of lung cancer with malignant pleural effusions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients diagnosed of lung cancer with malignant pleural effusions

You may qualify if:

  • lung cancer with malignant pleural effusions

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Pleural effusions and lung cancer tissue

MeSH Terms

Conditions

NeoplasmsLung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteLung DiseasesRespiratory Tract Diseases

Study Officials

  • Chao-Chi Ho

    Department of Internal Medicine and Emergency Medicine, National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chao-Chi Ho, Ph.D.

CONTACT

886-2-2356-2905ccho1203@ntu.edu.tw

Ang Yuan, Ph.D.

CONTACT

navyyuan@ntu.edu.tw

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 1, 2008

First Posted

June 4, 2008

Study Start

September 1, 2007

Study Completion

August 1, 2010

Last Updated

June 4, 2008

Record last verified: 2008-05

Locations

TW(1)